All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA ‘Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting’).
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).